Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.

Autor: Zhang J; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands., Boesjes CM; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Loman L; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands., Kamphuis E; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands., Romeijn MLE; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands., Spekhorst LS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Haeck I; Department of Dermatology, Reinier de Graaf Hospital, Delft, The Netherlands., van der Gang LF; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Dekkers CC; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Rijst LP; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Oosting AJ; Department of Dermatology, Spaarne Gasthuis, Hoofddorp, The Netherlands., van Lumig P; Department of Dermatology, University Medical Center Maastricht, Maastricht, The Netherlands., van Lynden-van Nes AMT; Department of Dermatology, Meander Medical Center, Amersfoort, The Netherlands., Tupker RA; Department of Dermatology, St Antonius Hospital, Nieuwegein, The Netherlands., Nijssen A; Department of Dermatology, Haga Hospital, Den Haag, The Netherlands., Flinterman A; Department of Dermatology, Diakonessenhuis, Utrecht, The Netherlands., Politiek K; Department of Dermatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Touwslager WRH; Department of Dermatology, Catharina Hospital, Eindhoven, The Netherlands., Christoffers WA; Department of Dermatology, Isala Hospital, Zwolle, The Netherlands., Stewart SM; Department of Dermatology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands., Kamsteeg M; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., de Graaf M; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., de Bruin-Weller MS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Schuttelaar MA; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: m.l.a.schuttelaar@umcg.nl.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Aug; Vol. 91 (2), pp. 300-311. Date of Electronic Publication: 2024 Apr 21.

Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial).

Autor: Ragamin A; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Department of Dermatology, Center of Pediatric Dermatology, Sophia Children's Hospital, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Schappin R; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Department of Dermatology, Center of Pediatric Dermatology, Sophia Children's Hospital, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., de Graaf M; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands., Tupker RA; Department of Dermatology, St. Antonius Hospital, Nieuwegein, the Netherlands., Fieten KB; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos Wolfgang, Switzerland.; Dutch Asthma Center Davos, Davos, Switzerland., van Mierlo MMF; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Bronner MB; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Romeijn GLE; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Sloot MM; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Boesjes CM; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands., van der Rijst LP; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands., Arents BWM; Dutch Association for People with Atopic Dermatitis, Nijkerk, the Netherlands., Rustemeyer T; Department of Dermatology and Allergology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Schuttelaar MLA; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Pasmans SGMA; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Department of Dermatology, Center of Pediatric Dermatology, Sophia Children's Hospital, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 342-354.

Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.

Autor: Boesjes CM; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., van der Gang LF; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Bakker DS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Ten Cate TA; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Spekhorst LS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., de Graaf M; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., van Dijk MR; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., de Bruin-Weller MS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2023 Nov 01; Vol. 159 (11), pp. 1240-1247.

Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies.

Autor: Boesjes CM; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., van Emst M; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Bakker DS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Spekhorst LS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., van Wijk F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., de Graaf M; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., de Bruin-Weller MS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2023 May; Vol. 53 (5), pp. 582-585. Date of Electronic Publication: 2023 Feb 13.

Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis: A Prospective Clinical Cohort Study From the BioDay Registry.

Autor: Spekhorst LS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., de Graaf M; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Loeff F; Sanquin Diagnostic Services, Sanquin, Amsterdam, the Netherlands., Zuithoff NPA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Bakker D; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Boesjes CM; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Thijs J; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., Achten R; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands., van Wijk F; Center for Translational Immunology, Division of Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Rispens T; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., de Bruin-Weller MS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, the Netherlands.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2022 Dec 01; Vol. 158 (12), pp. 1409-1413.